Pediatrix Medical Group, Inc.
NYSE•MD
CEO: Mr. Mark S. Ordan
Sector: Healthcare
Industry: Medical - Care Facilities
Listing Date: 1995-09-20
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Contact Information
Market Cap
$1.51B
P/E (TTM)
13.7
vs Industry 17.9
Dividend Yield (TTM)
--
52W High
$18.22
52W Low
$11.84
52W Range
2.7
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Weak • 2.7 / 9 points
Scoring Range (0-9) 
 8-9: Excellent Value
 6-7: Strong Fundamentals
 4-5: Average Quality
 0-3: Weak Performance
Data Period: 2015-2024
Financial Dashboard
Q2 2025 Data
Revenue
$468.84M-7.03% 
4-Quarter Trend
EPS
$0.45-124.46% 
4-Quarter Trend
FCF
$132.65M+32.67% 
4-Quarter Trend
Earnings Highlights
Key Highlights
No Data Available
Risk Factors
No Data Available
Outlook
No Data Available
Peer Comparison
Revenue (TTM)
$5.77B
 AHCO
AHCO$3.04B
$2.42B
Gross Margin (Latest Quarter)
 NVAX
NVAX94.1%
 GDRX
GDRX83.7%
 CNMD
CNMD55.0%
Key Metrics
| Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets | 
|---|---|---|---|---|
| SEM | $1.76B | 12.8 | 7.8% | 50.1% | 
| ASTH | $1.59B | 61.9 | 3.6% | 3.3% | 
| MD | $1.51B | 13.7 | 14.1% | 30.9% | 
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4-Quarter Revenue CAGR
-2.8%
Flat Growth
4-Quarter Net Income CAGR
+26.4%
Significant Improvement in Profitability
Cash Flow Stability
75%
Volatile Cash Flow
Research & Insights
Reports
All Years
- Form 10-Q - Q2 2025Period End: Jun 30, 2025|Filed: Aug 5, 2025|Revenue: $468.84M-7.0%|EPS: $0.45-124.5%Beat
- Form 10-Q - Q1 2025Period End: Mar 31, 2025|Filed: May 6, 2025|Revenue: $458.36M-7.4%|EPS: $0.24+400.0%Meet
- Form 10-K - FY 2024Period End: Dec 31, 2024|Filed: Feb 20, 2025|Revenue: $2.01B+0.9%|EPS: $-1.19-65.3%Miss
- Form 10-Q - Q3 2024Period End: Sep 30, 2024|Filed: Nov 1, 2024|Revenue: $511.16M+0.9%|EPS: $0.23-53.1%Miss
- Form 10-Q - Q2 2024Period End: Jun 30, 2024|Filed: Aug 6, 2024|Revenue: $504.30M+0.7%|EPS: $-1.84-641.2%Miss
- Form 10-Q - Q1 2024Period End: Mar 31, 2024|Filed: May 7, 2024|Revenue: $495.10M+0.8%|EPS: $0.05-71.8%Miss
- Form 10-K - FY 2023Period End: Dec 31, 2023|Filed: Feb 20, 2024|Revenue: $1.99B+1.1%|EPS: $-0.72-191.1%Miss
- Form 10-Q - Q3 2023Period End: Sep 30, 2023|Filed: Nov 2, 2023|Revenue: $506.61M+3.4%|EPS: $0.49+32.4%Beat